U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 3 Oral Hemorrhage, CTCAE

MedGen UID:
327286
•Concept ID:
C1560647
•
Finding

Definition

Transfusion indicated; invasive intervention indicated; hospitalization [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 3 Oral Hemorrhage, CTCAE

Recent clinical studies

Etiology

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).
Haller TJ, Yin XL, O'Byrne TJ, Moore EJ, Ma DJ, Price KP, Patel SH, Hinni ML, Neben-Wittich MA, McGee LA, Price DL, Janus JR, Kasperbauer JK, Nagel TH, Routman DM, Lester SC, Rwigema JCM, Chintakuntlawar AV, Savvides PS, Garcia JJ, Foote RL, Van Abel KM
Oral Oncol 2023 Feb;137:106248. Epub 2023 Jan 3 doi: 10.1016/j.oraloncology.2022.106248. PMID: 36603364
Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
Komrokji RS, Padron E, Yu D, Fulp WJ, Rodriguez Y, Tinsley S, List AF, Lancet JE
Am J Hematol 2014 Aug;89(8):809-12. Epub 2014 May 16 doi: 10.1002/ajh.23749. PMID: 24764152Free PMC Article

Therapy

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).
Haller TJ, Yin XL, O'Byrne TJ, Moore EJ, Ma DJ, Price KP, Patel SH, Hinni ML, Neben-Wittich MA, McGee LA, Price DL, Janus JR, Kasperbauer JK, Nagel TH, Routman DM, Lester SC, Rwigema JCM, Chintakuntlawar AV, Savvides PS, Garcia JJ, Foote RL, Van Abel KM
Oral Oncol 2023 Feb;137:106248. Epub 2023 Jan 3 doi: 10.1016/j.oraloncology.2022.106248. PMID: 36603364
Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
Cai Y, Guo H, Wang W, Li H, Sun H, Shi B, Zhang Y
Orphanet J Rare Dis 2018 Mar 27;13(1):43. doi: 10.1186/s13023-018-0781-y. PMID: 29587809Free PMC Article
Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
Komrokji RS, Padron E, Yu D, Fulp WJ, Rodriguez Y, Tinsley S, List AF, Lancet JE
Am J Hematol 2014 Aug;89(8):809-12. Epub 2014 May 16 doi: 10.1002/ajh.23749. PMID: 24764152Free PMC Article

Prognosis

Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
Komrokji RS, Padron E, Yu D, Fulp WJ, Rodriguez Y, Tinsley S, List AF, Lancet JE
Am J Hematol 2014 Aug;89(8):809-12. Epub 2014 May 16 doi: 10.1002/ajh.23749. PMID: 24764152Free PMC Article

Clinical prediction guides

Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
Komrokji RS, Padron E, Yu D, Fulp WJ, Rodriguez Y, Tinsley S, List AF, Lancet JE
Am J Hematol 2014 Aug;89(8):809-12. Epub 2014 May 16 doi: 10.1002/ajh.23749. PMID: 24764152Free PMC Article

Supplemental Content

Table of contents

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...